NZ591093A - Anti-inflammatory pharmaceutical compositions comprising a corticosteroid, hexylene glycol and water - Google Patents

Anti-inflammatory pharmaceutical compositions comprising a corticosteroid, hexylene glycol and water

Info

Publication number
NZ591093A
NZ591093A NZ591093A NZ59109309A NZ591093A NZ 591093 A NZ591093 A NZ 591093A NZ 591093 A NZ591093 A NZ 591093A NZ 59109309 A NZ59109309 A NZ 59109309A NZ 591093 A NZ591093 A NZ 591093A
Authority
NZ
New Zealand
Prior art keywords
percent
composition according
pharmaceutical composition
water
corticosteroid
Prior art date
Application number
NZ591093A
Other languages
English (en)
Inventor
Kerryn Greive
Original Assignee
Ego Pharmaceuticals Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2008905582A external-priority patent/AU2008905582A0/en
Application filed by Ego Pharmaceuticals Pty Ltd filed Critical Ego Pharmaceuticals Pty Ltd
Publication of NZ591093A publication Critical patent/NZ591093A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NZ591093A 2008-10-30 2009-10-30 Anti-inflammatory pharmaceutical compositions comprising a corticosteroid, hexylene glycol and water NZ591093A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2008905582A AU2008905582A0 (en) 2008-10-30 Anti-inflammatory compositions
PCT/AU2009/001420 WO2010048675A1 (fr) 2008-10-30 2009-10-30 Compositions pharmaceutiques anti-inflammatoires comprenant un corticostéroïde, de l'hexylène glycol et de l'eau

Publications (1)

Publication Number Publication Date
NZ591093A true NZ591093A (en) 2012-02-24

Family

ID=42128132

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ591093A NZ591093A (en) 2008-10-30 2009-10-30 Anti-inflammatory pharmaceutical compositions comprising a corticosteroid, hexylene glycol and water

Country Status (3)

Country Link
AU (1) AU2009310634B2 (fr)
NZ (1) NZ591093A (fr)
WO (1) WO2010048675A1 (fr)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4808610A (en) * 1986-10-02 1989-02-28 Schering Corporation Mometasone furoate anti-inflammatory cream composition using hexylene glycol
JP3830963B2 (ja) * 1993-12-21 2006-10-11 シェーリング コーポレイション 乾癬治療
TR200201343A2 (tr) * 2002-05-17 2003-12-22 Orva İlaç Sanayi̇ Ve Ti̇caret A. Ş. Kortikosteroid ve antiseptik içeren farmasötik bileşim
FR2898499B1 (fr) * 2006-03-15 2008-11-28 Galderma Sa Nouvelles compositions topiques sous forme d'emulsion h/e comprenant un glycol pro-penetrant
FR2898498B1 (fr) * 2006-03-15 2008-11-28 Galderma Sa Nouvelles compositions topiques sous forme d'emulsion h/e comprenant un glycol pro-penetrant
MX2010002592A (es) * 2007-09-10 2010-03-30 Glenmark Pharmaceuticals Ltd Composicion farmaceutica topica para la combinacion de acido fusidico y corticoesteroides.

Also Published As

Publication number Publication date
AU2009310634B2 (en) 2013-05-09
WO2010048675A1 (fr) 2010-05-06
AU2009310634A1 (en) 2010-05-06

Similar Documents

Publication Publication Date Title
US10588858B2 (en) Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
EP2374449B1 (fr) Composition comprenant au moins une phase aqueuse et au moins une phase grasse comprenant de l'ivermectine
Tamarkin Foam: a unique delivery vehicle for topically applied formulations
US20200230155A1 (en) Topical corticosteroid compositions
US20070224143A1 (en) Cosmetic and pharmaceutical foam carrier
US11179465B2 (en) Topical compositions comprising a corticosteroid
US20220273627A1 (en) Topical composition comprising tacrolimus
AU2009310634B2 (en) Anti-inflammatory pharmaceutical compositions comprising a corticosteroid, hexylene glycol and water
JP6503627B2 (ja) 医薬液体組成物
EP1624861A2 (fr) Nouvelles formulations en creme a base de steroide
JP7512365B2 (ja) 油性外用液
JP2023090338A (ja) 乳化組成物

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 30 OCT 2016 BY FREEHILLS PATENT ATTORNEYS

Effective date: 20130710

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 OCT 2017 BY FREEHILLS PATENT ATTORNEYS

Effective date: 20160802

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 OCT 2018 BY FPA PATENT ATTORNEYS PTY LTD

Effective date: 20170731

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 OCT 2019 BY FPA PATENT ATTORNEYS PTY LTD

Effective date: 20180730

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 OCT 2020 BY FPA PATENT ATTORNEYS PTY LTD

Effective date: 20190730

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 OCT 2021 BY FPA PATENT ATTORNEYS PTY LTD

Effective date: 20200730

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 OCT 2022 BY FPA PATENT ATTORNEYS PTY LTD

Effective date: 20210730

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 OCT 2023 BY FPA PATENT ATTORNEYS PTY LTD

Effective date: 20220801

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 OCT 2024 BY FPA PATENT ATTORNEYS PTY LTD

Effective date: 20230731